Marisa Cevasco
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Philadelphia, PANPI 1104098169
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $145,600 of the $185,925 with a category attached, or 78.3%. Abiomed accounts for 90.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $88,837 and has fallen 99.0% since, to $905 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 216 payments — averaging $860.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$169K
- Abbott$13K
- Edwards Lifesciences$3K
- Atricure, Inc.$572
- Medtronic$152
- Baxter Healthcare$149
- plus $221 from 2 others
Across 3 payments — averaging $635.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$2K
What the payments were for
- Consulting fees$7,0884%
- Speaking & faculty fees$145,60078%
- Travel & lodging$28,39915%
- Food & beverage$4,8383%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 120 | $169,003 |
| Abbott | 72 | $13,021 |
| Edwards Lifesciences | 6 | $2,806 |
| Atricure, Inc. | 11 | $572 |
| Medtronic | 1 | $152 |
| Baxter Healthcare | 2 | $149 |
| Boston Scientific | 1 | $114 |
| Johnson & Johnson | 3 | $107 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$168,226
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$10,402
- HeartMate 3 Left Ventricular Dev$736
- ATRICURE CRYOSURGICAL SYSTEM$253
- Epic Stented Tissue Valve$176
- HeartWare HVAD$152
- HeartMate$143
- HeartMate 3 Left Ventricular Assist Device$116
- INSPIRIS RESILIA aortic valve$112
- ATRICURE ATRICLIP LAA EXCLUSION$112
- CentriMag$110
- PREVELEAK$107
How this compares
$185,925 in reported general payments places this provider in the 95th percentile of 314 thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $197 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Philadelphia
- Mark AndersonPhiladelphia$527K
- Michael AckerPhiladelphia$271K
- Wilson SzetoPhiladelphia$252K
- Nimesh DesaiPhiladelphia$203K
- Nathaniel EvansPhiladelphia$187K
- Pavan AtluriPhiladelphia$165K
- Chase BrownPhiladelphia$137K
- Olugbenga OkusanyaPhiladelphia$132K
- Michael IbrahimPhiladelphia$66K
- Joshua GrimmPhiladelphia$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.